Accessibility Menu
Minimed Group logo

Minimed Group(NASDAQ) MMED

Current Price$16.73
Market Cap$4.59BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2026)-12%
5 YearN/A
1 YearN/A
1 Month+19%
Minimed Group last closing stock price
MetricPriceDate
Last closeUSD 16.332026-07-23
Minimed Group stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+2.83%USD 15.882026-07-16
1 month+18.85%USD 13.742026-06-23
3 month+23.71%USD 13.202026-04-24
Since inception-11.68%USD 18.492026-03-06

Minimed Group Financials at a Glance

Market Cap

$4.59BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$3.04K

Net Income (TTM)

-$468.00

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

0.35 (Low)

Price

$16.73

Volume

7,653

Open

$16.26

Previous Close

$16.33

Daily Range

$16.26 - $16.82

52-Week Range

$10.65 - $20.48

Estimated Earnings Date

Sep 1, 2026

MMED News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Minimed Group

MiniMed makes devices that help people manage diabetes every day. These tools track blood sugar and deliver insulin automatically. This helps patients spend less time worrying about their health.

Tools for Daily Diabetes Care

  • AID Systems: Automated Insulin Delivery (AID) systems use sensors and pumps to mimic a healthy pancreas; they adjust dosing every five minutes.
  • CGM Sensors: Continuous Glucose Monitoring (CGM) sensors measure blood sugar levels around the clock without needing painful finger pricks; part of the category representing 82% of revenue in fiscal year 2026.
  • Smart MDI System: The MiniMed Go platform includes smart insulin pens and apps for patients who prefer manual injections over wearing a pump.
  • Software and Supplies: The CareLink platform helps patients and doctors track health data, while infusion sets deliver insulin from pumps into the body.

Strategic Shifts and New Tech

  • Partnered with Abbott Diabetes Care, Inc. in July 2024 to integrate their advanced sensor technology into MiniMed systems.
  • Agreed to a funding deal with Blackstone Life Sciences Advisors L.L.C. to develop new insulin pump designs.
  • Launched the Simplera Sync sensor in the United States in September 2025 to simplify how patients start treatment.
  • Released the MiniMed Flex pump in the United States in June 2026, offering a smaller and rechargeable design.

Global Scale and Invention

MiniMed serves pump users in over 80 countries as of April 2026. The company owns over 2,000 patents and uses proprietary software to simulate patient data for faster research.

Performance by the Numbers

  • Revenue reached $3.1 billion in fiscal year 2026, up from $2.7 billion in fiscal year 2025.
  • Sales outside the United States made up 70% of total revenue in fiscal year 2026.
  • Net loss was $317 million in fiscal year 2026, up from a $198 million loss in 2025.
  • Adjusted EBITDA, a measure of core profitability, was $202 million in fiscal year 2026.

Evolution of Automated Care

MiniMed has moved from selling basic pumps to offering complete, automated systems for diabetes management. Its focus on global expansion and integrated software positions it to serve millions of patients needing intensive therapy.

AI Generated • Jun 30, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

8,000

CEO

Que Thanh Dallara, MBA

Website

www.minimed.com

Headquarters

Northridge, CA 91325, US

MMED Financials

Key Financial Metrics (TTM)

Gross Margin

52.91%

Operating Margin

-9.15%

Net Income Margin

-21.74%

Return on Equity

-14.45%

Return on Capital

1.30%

Return on Assets

-11.04%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

-44.81%

Stock Overview

Market Cap

$4.59BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

280.84M

Volume

7.65K

Avg. Volume

964.38K

Financials (TTM)

Gross Profit

$1.24B

Operating Income

-$215.00M

EBITDA

$22.00M

Operating Cash Flow

-$21.00M

Capital Expenditure

-$166.00M

Free Cash Flow

-$187.00M

Cash & ST Invst.

$298.00M

Total Debt

$145.00M

Minimed Group Performance Analysis

Minimed Group annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20252025-04-30USD 2,715,000,000N/A
20262026-04-30USD 3,102,000,00014.3%
Minimed Group sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42025-04-30N/A
Q22025-10-31N/A
Q32026-01-31N/A
Q42026-04-245.9%
Minimed Group annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20252025-04-30USD -0.76N/A
20262026-04-30USD -1.1956.3%
Minimed Group sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42025-04-30N/A
Q22025-10-31N/A
Q32026-01-31N/A
Q42026-04-24-61.9%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$837.00M

N/A

Gross Profit

$480.00M

N/A

Gross Margin

57.35%

N/A

Market Cap

$4.59BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$573.27K

N/A

Employees

8,000

N/A

Net Income

-$183.00M

N/A

EBITDA

$82.00M

N/A

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Total Cash

$298.00M

N/A

Total Debt

$145.00M

N/A

Accounts Receivable

$655.00M

N/A

Inventory

$341.00M

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$145.00M

N/A

Return on Assets

-11.04%

N/A

Return on Invested Capital

-5.47%

N/A

Free Cash Flow

-$226.00M

N/A

Operating Cash Flow

-$170.00M

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,399.15-0.01%
^DJIDJI
$51,649.46-0.01%
^IXICNASDAQ
$25,099.92-0.02%
BTCBitcoin
$64,725.00-0.02%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.41-0.05%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$44.32+0.02%
MUUDirexion Shares ETF Trust - Direxion Daily Mu Bull 2x Shares
$32.26-0.12%
TAT&T
$23.63+0.03%

Questions About MMED

What is the current price of Minimed Group?

Minimed Group is trading at $16.73 per share.

What is the 52-week range for Minimed Group?

Over the past 52 weeks, Minimed Group has traded between $10.65 and $20.48.

How much debt does Minimed Group have?

As of the most recent reporting period, Minimed Group reported total debt of $53.00M.

How much cash does Minimed Group have on hand?

Minimed Group reported $298.00M in cash and cash equivalents in its most recent financial results.

What is Minimed Group’s dividend yield?

Minimed Group does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services